L Potts
Overview
Explore the profile of L Potts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
398
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hildersley R, Potts L, Anderson C, Henderson C
Epidemiol Psychiatr Sci
. 2020 Nov;
29:e177.
PMID: 33148367
Aims: Time to Change, an anti-stigma programme in England, has worked to reduce stigma relating to mental illness in many facets of life. Newspaper reports are an important factor in...
2.
Thompson R, Agostini K, Potts L, Luscombe J, Christie D, Viner R, et al.
Diabet Med
. 2012 Sep;
30(4):491-4.
PMID: 22998504
Aims: Deprivation and/or ethnicity impact on care delivery. We have assessed how these factors influence diabetes care in a paediatric clinic. Methods: We related access to care [type of insulin...
3.
Potts L, Eshleman J, Cooper J
Behav Anal
. 2012 Apr;
16(2):177-89.
PMID: 22478145
This paper presents the historical developments of precision teaching, a technological offshoot of radical behaviorism and free-operant conditioning. The sequence progresses from the scientific precursors of precision teaching and the...
4.
White P, Goldsmith K, Johnson A, Potts L, Walwyn R, DeCesare J, et al.
Lancet
. 2011 Feb;
377(9768):823-36.
PMID: 21334061
Background: Trial findings show cognitive behaviour therapy (CBT) and graded exercise therapy (GET) can be effective treatments for chronic fatigue syndrome, but patients' organisations have reported that these treatments can...
5.
Wong I, Asherson P, Bilbow A, Clifford S, Coghill D, DeSoysa R, et al.
Health Technol Assess
. 2009 Nov;
13(50):iii-iv, ix-xi, 1-120.
PMID: 19883527
Objectives: To estimate the prevalence of attention deficit hyperactivity disorder (ADHD) pharmacological treatment, and its demographic and clinical details, and to estimate the proportion of patients in the target group...
6.
Ho G, Mowat A, Potts L, Cahill A, Mowat C, Lees C, et al.
Aliment Pharmacol Ther
. 2009 Feb;
29(5):527-34.
PMID: 19183339
Background: Adalimumab is a second generation humanized anti-tumour necrosis factor (TNF) monoclonal antibody with established efficacy in Crohn's disease (CD). Aims: To evaluate the efficacy and safety of adalimumab on...
7.
Tannenbaum R, King S, Lecy J, Tirrell M, Potts L
Langmuir
. 2005 Jun;
20(11):4507-14.
PMID: 15969159
In this paper, we studied the kinetics of the adsorption of poly(methyl methacrylate), PMMA, onto native aluminum oxide surfaces by X-ray photoelectron spectroscopy and reflection-absorption infrared spectroscopy, with the intent...
8.
Maetz H, Walton W, Smith M, Lincoln R, Galvin M, Tryon C, et al.
J Public Health Manag Pract
. 1998 Aug;
4(5):46-55.
PMID: 10187066
"A Satellite Primer on Tuberculosis" was offered as a distance-based certificate course on tuberculosis (TB) fundamentals to a national audience of over 5,000 individuals. The course was a collaborative effort...
9.
Potts L, Rowitz L
J Public Health Manag Pract
. 1997 Mar;
2(4):73-6.
PMID: 10186702
No abstract available.
10.
Potts L, Cross S, MacLennan W, Watt B
Arch Gerontol Geriatr
. 1996 Sep;
23(2):153-61.
PMID: 15374159
Patients over the age of 65 years with clear catch specimens of urine containing organisms sensitive to norfloxacin were blindly randomised to receive either norfloxacin in a dose of 400...